Liposomal NAD+ and NMN: Does the Delivery Claim Hold Up? (2026)
Liposomal NAD+ and liposomal NMN wrap the active compound in phospholipid spheres to protect it through digestion. The concept borrows from pharmaceutical drug delivery, but the supplement versions have almost no human data behind them. One small 2025 trial (15 men, 4 weeks) found liposomal NMN raised blood NAD+ more than standard NMN. But the study had only 5 participants per group, and its statistical methods have been questioned by independent reviewers. Standard oral NMN capsules, by contrast, have multiple larger trials confirming they raise NAD+ reliably. YourHealthier NMN 500mg uses the standard capsule format tested in human NMN trials, with a third-party Certificate of Analysis for each lot covering potency, heavy metals, and microbiology.
Liposomal delivery is proven to enhance absorption of certain nutrients. A 2024 double-blind trial showed liposomal vitamin C reached 27% higher peak plasma levels (Cmax) than standard vitamin C, and a 2025 scoping review across 10 studies confirmed the pattern. But for NAD+ and NMN specifically, the evidence gap is enormous: no large human trial has ever tested whether liposomal wrapping translates into better clinical outcomes than a standard capsule. This article breaks down exactly what the data does and does not support, so you can decide whether the premium price is justified.
What Is Liposomal NAD+?
Liposomal NAD+ is nicotinamide adenine dinucleotide (NAD+) enclosed in liposomes, the microscopic phospholipid spheres designed to shield the molecule from stomach acid and improve how much reaches your cells. Liposomal NMN applies the same encapsulation to NMN, a direct NAD+ precursor.
The idea is straightforward: NAD+ is a large, water-soluble molecule that breaks down quickly in stomach acid. Encasing it in a lipid shell should, in theory, protect it through the digestive tract and allow more of the intact molecule to reach the bloodstream. The same logic applies to liposomal NMN (also called lipo NMN). NMN is a direct NAD+ precursor that your cells convert into NAD+ through a well-characterized enzymatic pathway.
You'll see the terms used interchangeably online (NAD liposomal, NAD+ liposomal, NMN liposomal, lipo NMN), but they all describe this same approach: wrapping an NAD-related molecule in a phospholipid carrier. Both products typically come as capsules or liquid formulations, and both carry significantly higher price tags than their standard counterparts. The critical question isn't whether the delivery concept makes sense in theory. It does. The question is whether the concept has been validated for these specific molecules, at supplement doses, in actual human beings.
How Liposomal Delivery Works — and Where It Breaks Down
Pharmaceutical liposomes are well-established. They've been used since the 1990s in FDA-approved drugs like liposomal doxorubicin (Doxil) for cancer treatment. The technology does improve delivery of certain compounds, and the science behind it is established.
The mechanism works like this. Phospholipids naturally arrange themselves into bilayer spheres when mixed with water. A water-soluble compound like NAD+ gets trapped in the aqueous core. When these liposomes reach the small intestine, they can fuse with intestinal cell membranes (both are made of the same phospholipid material) and release their payload directly into cells, bypassing some of the normal digestive breakdown.
That's the textbook version. In practice, oral supplement liposomes face three problems that pharmaceutical liposomes don't:
Gastric degradation. A 2018 review in the journal Acta Pharmaceutica Sinica B documented that conventional liposomes are highly susceptible to the combined effects of stomach acid, bile salts, and pancreatic enzymes. After 120 minutes in simulated intestinal fluid, the majority of liposomes showed irregular shapes and obviously damaged membranes. Only a small fraction remained intact. Pharmaceutical liposomes get around this with PEGylation and other coatings. Most supplement liposomes don't.
Storage instability. Liposomes can leak their contents during storage, especially at room temperature. The phospholipid bilayer degrades over time through oxidation and hydrolysis. A supplement sitting on a warehouse shelf or in transit for weeks is not the same product that left the manufacturer. Unlike pharmaceutical products, supplement liposomes don't routinely undergo stability testing under real-world storage conditions.
No standardization. "Liposomal" is an unregulated marketing term in the supplement industry. There's no required particle size, no minimum encapsulation efficiency, no stability standard. A product labeled "liposomal" could contain true nano-liposomes, or it could contain phospholipids loosely mixed with the active ingredient without meaningful encapsulation.
Liposomal NAD+ Benefits: What the Evidence Actually Shows
Search for "liposomal NAD+ benefits" or "liposomal NMN benefits" and you'll find bold claims about superior absorption, faster NAD+ restoration, and cellular protection. The potential liposomal NAD benefits fall into two categories: what's been demonstrated in lab settings, and what's been tested in humans. The gap between these two categories is wide.
Lab and skin-model evidence
A 2025 study in Current Issues in Molecular Biology tested a liposomal NAD+ formulation (LF-NAD+) in human endothelial cells, skin cells, and an ex vivo skin model. The results were notable: LF-NAD+ increased intracellular NAD+ levels more effectively than NAD+ alone, reduced markers of cellular aging (senescence-associated β-galactosidase), and improved NAD+ delivery across the skin layers measured ex vivo by infrared spectroscopy. The researchers used a formulation based on Natipide® II, a well-characterized phospholipid system.
These findings are relevant for topical applications, since the study was designed for cosmetic dermatology. They do not tell us what happens when you swallow a liposomal NAD+ capsule.
The one human trial on liposomal NMN
A 2025 study by Kawakami et al., published in Annals of Clinical and Medical Case Reports, conducted a randomized, double-blind, placebo-controlled trial comparing liposomal NMN, non-liposomal NMN, and placebo in 15 healthy men over 40 years old. Participants took 350 mg daily for 4 weeks.
The result: the liposomal NMN group showed a statistically significant increase in blood NAD+ compared to both the non-liposomal group and placebo. The non-liposomal group did not differ significantly from placebo.
Before drawing conclusions, note the limitations:
• Only 5 participants per group. A single outlier in any arm could swing the results entirely.
• The statistical analysis has been questioned by outside reviewers, including the team at Renue by Science's trial database, which notes concerns about the data analysis and methods.
• The journal (Annals of Clinical and Medical Case Reports) is not a high-impact publication, and the study hasn't been replicated.
• The non-liposomal NMN group failing to separate from placebo at 350 mg contradicts multiple larger trials showing standard NMN raises NAD+ at similar doses.
This is a single exploratory finding, not a proven advantage. It would need replication in a much larger trial before it could support any marketing claim.
What standard oral NMN has
By contrast, standard oral NMN capsules, the kind used in research, have a substantially larger evidence base. A 2025 meta-analysis by Zhang et al. pooled data from 513 participants across 12 trials and confirmed that oral NMN reliably raises blood NAD+ levels, with a dose up to 1,250 mg/day tolerated without significant liver-enzyme changes. The first head-to-head human trial of NAD+ precursors, Christen et al. (2026, Nature Metabolism), went further: in 65 healthy adults, 14 days of standard NMN at 1,000 mg/day roughly doubled circulating NAD+, matching nicotinamide riboside (NR). A 2026 systematic review by Yang et al. in Nutrients, covering short-term randomized trials, reinforced NMN's safety profile with no increase in adverse events or liver biochemistry.
When someone asks "what are the benefits of liposomal NAD+?" the honest answer is: no published trial on liposomal NMN or liposomal NAD+ comes close to this evidence base.
Does Liposomal NAD+ Work? The Honest Assessment
Short answer: The liposomal delivery concept is scientifically valid and proven for nutrients like vitamin C, but it has not been proven for NAD+ or NMN specifically. Standard oral NMN capsules have far stronger human evidence that they raise NAD+ than any liposomal formulation.
The answer depends on what "work" means:
Does the liposomal concept have scientific merit? Yes. Liposomal delivery improves bioavailability for some compounds. A 2025 scoping review of liposomal vitamin C found that 9 out of 10 human studies showed higher bioavailability (between 1.2 and 5.4 times higher peak concentrations) for the liposomal form.
Has this been proven for NAD+ or NMN specifically? No. One small exploratory trial is not proof. The gap in evidence is not a matter of interpretation. It sits between one n=15 trial (with noted methodological concerns) and zero others.
Does a standard oral NMN capsule actually work? Yes, with much stronger evidence. Multiple independent trials confirm standard capsules reliably raise blood NAD+ levels. The concern that "NMN doesn't survive digestion without liposomal protection" is not supported by the clinical data. It clearly does.
Liposomal NAD+ Side Effects and Safety
Liposomal NAD+ side effects, and liposomal NAD side effects more broadly, mirror what's reported for standard NAD+ supplements. The reported side effects of NAD+ supplements in general are mild and typically dose-dependent: nausea, headache, fatigue, dizziness, and digestive discomfort (bloating, loose stools) during early use. These effects are generally associated with NAD+ itself, not the liposomal delivery.
Specific safety data on liposomal NAD+ formulations is extremely limited. No long-term study has evaluated liposomal NAD+ or liposomal NMN supplements over months or years. The phospholipid shell itself (typically soy or sunflower lecithin) is generally recognized as safe, but people with soy allergies should check labels carefully.
NAD+ supplements of any format may interact with certain metabolic processes. Because NAD+ is involved in energy metabolism, sensitive individuals have reported temporary changes in sleep patterns or blood pressure. People with liver conditions, blood pressure disorders, or those taking medications that affect methylation pathways should consult a healthcare provider before starting any NAD+ supplement, liposomal or otherwise.
Liposomal NAD+ with Resveratrol — Does Combining Them Help?
Short answer: Combining NAD+ (or NMN) with resveratrol is biologically reasonable because both activate sirtuin enzymes, but no clinical trial has tested a combined liposomal NAD+-resveratrol product. You can get the same ingredients more cheaply by taking a standard NMN capsule with resveratrol and a fat source.
Products marketed as "liposomal NAD+ resveratrol" or "NAD liposomal resveratrol" bundle both compounds into the same formulation. The rationale comes from the NMN-plus-resveratrol stack popularized by Dr. David Sinclair's longevity research. Both compounds activate sirtuin enzymes, which use NAD+ as a cofactor.
Resveratrol does have some human research behind it, particularly for cardiovascular markers and inflammatory biomarkers. And because resveratrol is fat-soluble, liposomal delivery could theoretically improve its absorption more than it improves absorption of water-soluble compounds like NAD+.
That said, no trial has tested a combined liposomal NAD+-resveratrol formulation as a single product. The combination is reasonable in concept but unvalidated as a package. If you want both, you can take a standard NMN capsule alongside resveratrol (with a fat source for absorption) and get the same ingredients at lower cost.
Liposomal NAD+ Supplements for Women
"Liposomal NAD supplement for women" has become its own search category. NAD+ levels decline with age in both sexes, but the trajectory in women has some distinct characteristics. Estrogen influences NAD+ metabolism, and the hormonal shifts during perimenopause and menopause accelerate NAD+ decline. A 2020 study in Cell Reports found that restoring NAD+ levels through NMN improved ovarian function and egg quality in aging mice, though no human trial has confirmed this.
One human trial used 250 mg NMN daily for 10 weeks in postmenopausal women and found improvements in muscle insulin sensitivity. This remains the only trial specifically studying NMN in a female population.
The liposomal delivery format has no special advantage for women. The claim that "liposomal NAD+ supplement for women" represents something distinct from liposomal NAD+ for anyone else is a marketing segmentation, not a scientific one. Women considering NAD+ support should evaluate the same factors as anyone else: evidence quality, purity, dose, and cost.
NMN Capsule vs. Liposomal vs. Sublingual vs. Powder: How Delivery Formats Compare
Short answer: The standard capsule is the only NMN format with a robust human-trial evidence base. Liposomal, sublingual, and powder formats may work, but none has been shown to outperform a standard capsule in a well-designed trial.
This is the practical question behind the liposomal marketing. If you've decided to supplement with an NAD+ precursor, which format actually makes sense? This is what the research supports for each:
| Format | Human trial evidence | Practical considerations |
|---|---|---|
| Standard capsule | Most-studied format; used in the majority of NMN and NR trials. Confirmed to raise NAD+ at 250–1,250 mg/day. | Shelf-stable, affordable, easy to dose. The evidence baseline. |
| Liposomal capsule/liquid | One n=15 exploratory trial (liposomal NMN). No trials on liposomal NAD+ capsules. | Usually priced well above standard capsules. Storage-sensitive. Variable encapsulation quality. |
| Sublingual | No published head-to-head trial vs. capsule for NMN or NR. | Bypasses first-pass liver metabolism in theory. Compliance can be challenging (holding under tongue). |
| Powder | Used in some trials. Functionally equivalent to capsule contents. | Cheaper per mg. Requires weighing. NMN degrades faster when exposed to moisture and air. |
The standard capsule is the only format with a robust evidence base. That doesn't mean other formats can't work. It means they haven't been shown to work better. Our NMN supplement comparison evaluates products primarily on the factors that are validated: purity (≥99% HPLC), third-party testing, and dose accuracy.
How to Choose a Liposomal NAD+ or NMN Supplement
If you've weighed the evidence and still want to try a liposomal NAD supplement or liposomal NMN supplement, these are the factors to look for, and the ones to be skeptical about. Note that "best liposomal NMN supplement" and "best liposomal NMN" are among the most-searched phrases in this category, so the market is paying attention even as the science lags behind:
Encapsulation evidence. Ask whether the manufacturer publishes encapsulation efficiency, meaning the percentage of active ingredient actually enclosed in liposomes versus floating free. Most supplement brands don't disclose this. Without it, you're paying a liposomal premium for what might be standard NMN mixed with lecithin.
Particle size. Effective liposomes are typically under 200 nm. Larger particles are less likely to survive digestion intact. Few supplement brands publish particle-size data.
Purity and COA. Whether liposomal or standard, the active ingredient still needs to be pure. Look for ≥99% HPLC purity with a current, third-party Certificate of Analysis.
Storage requirements. Liposomal products are inherently less stable than standard capsules. Check whether the product requires refrigeration and whether the supply chain supports cold storage.
Price per mg of active ingredient. Liposomal NMN typically costs more per milligram than standard NMN capsules; compare the price per milligram of NMN on each label. The question is whether the potential (unproven) absorption advantage justifies that premium. If you are also weighing clinic options, our NAD+ therapy cost guide compares IV drips, injections, and oral supplements side by side.
Brand Snapshot: Liposomal NAD+ and NMN Products
Searching for "liposomal NAD+ reviews" returns a long list of brands, but almost no independent testing. The liposomal NAD+ and NMN market includes several well-known brands. Below is a brief, evidence-focused look at the major products, none of which have published independent clinical trials on their specific formulations:
Rho Nutrition Liposomal NAD+
Rho Nutrition (also searched as "Rho liposomal NAD+" and "Rho Nutrition liposomal NAD+") is one of the most-searched liposomal NAD+ brands. Their product delivers NAD+ directly (not a precursor) in a liquid liposomal format. Rho positions itself as a premium option and prices accordingly. The key question for any direct NAD+ product is whether the molecule survives digestion. NAD+ is large and unstable, and liposomal protection is the mechanism Rho relies on. No published human trial has tested Rho's specific formulation.
Cymbiotika Liposomal NAD+
Cymbiotika uses a liquid liposomal format with additional ingredients. Their marketing emphasizes the absorption angle. Like Rho, no independent clinical trial has validated their specific product's bioavailability claims.
Codeage Liposomal NMN and NAD+ Capsules
Codeage offers both Codeage liposomal NMN capsules (available in 30-count and 90-count) and Codeage liposomal NAD+ capsules. The capsule format is more convenient than liquids, though capsule-based liposomal delivery has less supporting data than liquid formulations. Codeage has a broad supplement line but does not publish encapsulation efficiency data for their liposomal products.
Renue by Science NAD+ Complete (Liposomal)
Renue by Science (formerly Alive by Science) is one of the more transparent brands in this space. They offer multiple NAD+ precursors in liposomal format, including their lipo NMN, and have published some of their manufacturing specifications. Their website hosts a comprehensive NMN trial database and acknowledges limitations in the liposomal evidence base, an unusual level of candor for the industry.
ProHealth Longevity Liposomal NMN Pro 300 / Pro Complete
ProHealth Longevity offers both standard and liposomal NMN products. Their ProHealth liposomal NMN Pro 300 uses Uthever® NMN in a liposomal capsule format. The Pro Complete adds TMG and other co-factors. ProHealth is generally well-regarded for transparency and uses third-party testing, though the liposomal advantage over their standard capsule has not been independently verified.
Purovitalis Liposomal NMN Capsules
Purovitalis is a European brand that emphasizes liposomal NMN. They've published content about the Kawakami 2025 study, though that study did not test their specific product. Purovitalis positions itself as a premium European alternative.
GenuinePurity Liposomal NMN
GenuinePurity (also listed as Genuine Purity liposomal NMN) markets a liposomal NMN product with a 98% purity claim. The product appears in NMN roundup lists and is marketed toward the longevity-focused consumer. Standard caveats apply: no published trial on their specific formulation.
The Bottom Line: Is Liposomal NAD+ Worth It?
Short answer: For most people, no. The premium price of liposomal NAD+ and NMN is not yet justified by the evidence. A high-purity standard NMN capsule has stronger clinical support for raising NAD+ and usually costs less per milligram.
Liposomal delivery is well-established technology with proven applications. It works for vitamin C. It works in pharmaceutical drug delivery. The concept is scientifically sound.
But for NAD+ and NMN supplements specifically, the evidence does not yet support the premium pricing. One small exploratory trial with noted methodological issues is not enough to conclude that liposomal NMN outperforms standard NMN. And for liposomal NAD+ (the direct molecule, not a precursor), there is no human oral supplementation trial at all. The only published data involves cell culture and skin models.
Meanwhile, standard oral NMN in capsule form, the format used in every major clinical trial, has been shown across hundreds of participants to reliably raise NAD+ levels with good tolerability and no serious adverse events.
If cost is not a concern and you want to try the newer delivery format, look for brands that publish encapsulation efficiency data and third-party purity testing. But if you're optimizing for evidence-backed NAD+ support, a high-purity standard NMN capsule remains the better-supported choice.
YourHealthier NMN 500mg comes in the same standard capsule format used in the human trials showing NMN raises NAD+, at $49.95 for 30 capsules, with a third-party Certificate of Analysis for each lot covering potency, heavy metals, and microbiology.
Frequently Asked Questions
What is liposomal NAD+?
Liposomal NAD+ is nicotinamide adenine dinucleotide enclosed in phospholipid spheres (liposomes) designed to protect the molecule through digestion and improve cellular uptake. The technology is borrowed from pharmaceutical drug delivery. In supplement form, quality and effectiveness vary widely because there are no industry standards for liposomal supplement manufacturing.
What is liposomal NMN?
Liposomal NMN applies the same phospholipid encapsulation to nicotinamide mononucleotide, a direct NAD+ precursor. The goal is the same, improved absorption, though standard NMN capsules have already been shown to raise NAD+ effectively in multiple human trials.
What are liposomal NAD+ benefits?
The theoretical benefit is improved bioavailability through the digestive tract. A 2025 lab study showed liposomal NAD+ delivered more NAD+ into human cells and skin tissue than free NAD+. However, no human clinical trial has demonstrated that oral liposomal NAD+ supplements produce better health outcomes than standard NAD+ precursors like NMN or NR.
What are liposomal NAD+ side effects?
Reported side effects are generally mild: nausea, headache, fatigue, digestive discomfort, and occasional flushing. These are associated with NAD+ itself rather than the liposomal format. Long-term safety data specific to liposomal NAD+ formulations does not exist. People with soy allergies should check whether the product uses soy-derived phospholipids.
Is liposomal NAD+ better than standard NAD+ supplements?
"Better" hasn't been demonstrated in humans. The single existing trial compared liposomal NMN to standard NMN (not direct NAD+), used only 15 participants, and has noted methodological concerns. Until larger, well-designed trials confirm an advantage, the claim that liposomal is superior remains unproven. Standard NAD+ precursors (NMN, NR) have a much stronger clinical evidence base.
Which is the best liposomal NAD+ supplement?
No liposomal NAD+ or NMN product has been validated in an independent clinical trial, so "best" can only be judged on manufacturing transparency: published encapsulation efficiency, third-party purity testing, particle-size data, and cold-chain storage protocols. Renue by Science and ProHealth Longevity are among the more transparent brands. For evidence-backed NAD+ support regardless of format, see our full NMN supplement comparison.
Does liposomal NAD+ work for women specifically?
NAD+ biology doesn't differ by delivery format between sexes. Women experience accelerated NAD+ decline around menopause due to hormonal shifts, and one trial showed NMN improved insulin sensitivity in postmenopausal women, but that trial used standard NMN, not liposomal. Products marketed as "liposomal NAD+ for women" are not formulated differently in any evidence-backed way.
This article is written for general educational purposes and is not medical advice. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. NAD+ precursor supplements are not a treatment for menopause, diabetes, or any medical condition. Consult a qualified healthcare provider before starting any supplement, especially if you are pregnant, nursing, or taking medication.
References
Kawakami S, Maeda Y, Fukuzawa Y. Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide. Ann Clin Med Case Rep. 2025;14(11):1–12.
Ministrini S, Liberale L, Erle HE, et al. A Liposomal Formulation Enhances the Anti-Senescence Properties of Nicotinamide Adenine-Dinucleotide (NAD+) in Endothelial Cells and Keratinocytes. Curr Issues Mol Biol. 2025;47(9):722. PMC12468054
Zhang J, Poon ETC, Wong SHS. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Crit Rev Food Sci Nutr. 2025;65(22):4382–4400. PMID: 39116016
Christen S, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026;8:62–73. DOI: 10.1038/s42255-025-01421-8
Yang W, et al. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(14):2251. PMC13414721
Carr AC. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review. Basic Clin Pharmacol Toxicol. 2025;137(1):e70067. DOI: 10.1111/bcpt.70067
Purpura M, et al. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. Eur J Nutr. 2024;63(8):3037–3046. PMID: 39472360
He J, et al. Adapting liposomes for oral drug delivery. Acta Pharmaceutica Sinica B. 2019;9(1):36–48. DOI: 10.1016/j.apsb.2018.06.005
Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PMID: 33888596
Want to see YourHealthier first when you search Google? Add us as a preferred source.
Sources verified: All PubMed citations and external references in this article were last verified on September 21, 2026.
Disclosure: YourHealthier manufactures and sells the supplements discussed in this article. All health claims are based on published peer-reviewed research cited above. We earn revenue from product sales linked in this article.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
Want to see YourHealthier first when you search Google? Add us as a preferred source.